Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab.
Wermke
Martin
M
von Bonin
Malte
M
Gehrisch
Siegmund
S
Siegert
Gabriele
G
Ehninger
Gerhard
G
Platzbecker
Uwe
U
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D005169:Factor VIII